⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9767781 | 1.00 | — | — | |
| SCHEMBL9767564 | 0.87 | AGTR1 (0.53) | — | |
| SCHEMBL9871423 | 0.87 | AGTR1 (0.53) | — | |
| SCHEMBL9767626 | 0.84 | AGTR1 (0.46) | — | |
| SCHEMBL9767407 | 0.84 | AGTR1 (0.46) | — | |
| SCHEMBL9767511 | 0.83 | AGTR2 (0.62) | — | |
| SCHEMBL9767507 | 0.83 | AGTR2 (0.62) | — | |
| SCHEMBL9767531 | 0.81 | AGTR1 (0.55) | — | |
| SCHEMBL9767515 | 0.81 | AGTR1 (0.55) | — | |
| SCHEMBL352 | 0.80 | AGTR1 (0.64) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5041552-A | Treatment of hypertension, heart failure, glaucoma and hyperaldosteronism | WARNER-LAMBERT COMPANY (US) | 1991-08-20 | — | — | US | disclosed |